Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 1/13/2026

Acute Management of Traumatic Spinal Cord Injury

Hemodynamic Management

  • Maintain a mean arterial pressure (MAP) > 85 mmHg for the first 5–7 days after injury to optimize spinal cord perfusion; this target is recommended by the American Association of Neurological Surgeons/Congress of Neurological Surgeons (AANS/CNS) based on limited evidence from uncontrolled studies. Strength: weak/limited evidence. 1

  • If MAP > 85 mmHg cannot be achieved, a minimum MAP > 70 mmHg is acceptable according to French national guidelines, which note insufficient evidence to support higher targets. Strength: weak/limited evidence. 1

  • Spinal perfusion pressure (SPP) > 50 mmHg correlates with better 6‑month neurological outcomes, emphasizing the importance of maintaining adequate MAP. Strength: observational correlation. 1

  • Arterial line placement for continuous blood‑pressure monitoring is advised, because intermittent cuff measurements miss ≈ 25 % of hypotensive episodes. Strength: moderate evidence. 1

  • Avoid any systolic blood‑pressure < 90 mmHg during the first 5–7 days, as hypotension is an independent predictor of mortality. Strength: moderate evidence. 1

Pharmacologic Management

  • Use vasopressor agents to achieve MAP targets when fluid resuscitation alone is insufficient; titrate to maintain MAP ≥ 70 mmHg (or ≥ 85 mmHg per institutional protocol). Strength: consensus recommendation. 2

Steroid Therapy

  • Methylprednisolone is contraindicated in acute spinal cord injury; the Congress of Neurological Surgeons and the American Association of Neurological Surgeons issue a strong recommendation against its use. Strength: strong recommendation (GRADE 1). 3

  • High‑dose steroids increase infectious complications, with infection rates roughly double those of placebo. Strength: moderate evidence from cohort analyses. 1

Surgical Timing

  • Perform emergency decompressive surgery within 24 hours of neurological deficit to improve long‑term neurological recovery. Early surgery (< 24 h) is associated with an 8.9‑fold increase in the relative risk of neurological improvement. Strength: moderate evidence (observational). 4

  • Ultra‑early surgery (< 8 hours) may further reduce pulmonary complications and enhance recovery in hemodynamically stable patients. Strength: limited evidence. 4

Transfer to Specialized Care

  • Transfer all traumatic spinal cord injury patients immediately to a specialized spinal‑injury unit; specialized care reduces morbidity and long‑term mortality (GRADE 2+ recommendation). Strength: moderate evidence. 1

Urological Management

  • Remove indwelling urinary catheters as soon as the patient is medically stable and initiate intermittent catheterization to lower rates of urinary‑tract infection, urolithiasis, and to improve continence. Strength: moderate evidence. 5

  • Begin intermittent catheterization once daily urine output is adequate, using a voiding calendar to schedule catheterizations. Strength: consensus. 5

Risk Stratification & Timing of Urodynamics

  • Delay formal risk‑stratification and urodynamic studies until spinal shock has resolved and neurological status has stabilized; spinal shock typically resolves in 3–6 months (up to 1–2 years). Testing during shock yields unreliable data. Strength: expert opinion. 6

Prevention of Secondary Complications

Pressure‑Ulcer Prevention

  • Reposition patients every 2–4 hours and perform pressure‑zone checks, employing high‑level support surfaces (e.g., air‑loss or dynamic mattresses). Strength: moderate evidence. 5

  • Conduct daily visual and tactile examinations of all at‑risk areas and initiate early mobilization once the spine is stabilized. Strength: consensus. 5

Early Rehabilitation

  • Start comprehensive rehabilitation within the first days after injury, including at least 20 minutes of zone‑specific stretching, to promote neurotrophic factors that support axonal regeneration. Strength: moderate evidence. 7

MAP Targets in Acute Traumatic Spinal Cord Injury – Evidence‑Based Guidance

Rationale for Elevated MAP Targets

  • The higher MAP range of 75–95 mmHg after traumatic spinal cord injury is intended to counteract secondary injury mechanisms (edema, raised intraspinal pressure, loss of autoregulation) rather than reflecting a unique baseline perfusion requirement of the healthy spinal cord. 8

Guideline Recommendations

  • Global Spine Journal (2024) guideline: Maintain MAP 75–80 mmHg (lower limit) to 90–95 mmHg (upper limit) for 3–7 days post‑injury to optimise spinal cord perfusion; recommendation is weak and based on very low‑quality evidence. 9
  • American Association of Neurological Surgeons / Congress of Neurological Surgeons: Previously advised MAP >85 mmHg for 5–7 days; this guidance derives from uncontrolled prospective studies without comparator groups. 8
  • French spinal‑injury guideline: Suggests MAP >70 mmHg may be sufficient, noting insufficient evidence to support higher targets. 9

Evidence Base and Limitations

  • No randomized controlled trials have compared different MAP targets in acute spinal cord injury; current recommendations rely on observational data and expert opinion. 8
  • A small retrospective cohort (≈17 patients) showed that longer exposure to MAP <65–70 mmHg correlated with poorer neurological improvement, whereas this relationship vanished at MAP thresholds of 75, 80, or 85 mmHg, indicating limited benefit above 70 mmHg. 9
  • The association between higher MAP and neurological recovery is strongest during the first 2–3 days after admission and diminishes thereafter. 8

Implementation Challenges

  • Even in specialised spinal‑injury centres with prospective haemodynamic monitoring, patients spend roughly 25 % of the monitoring period below the prescribed MAP target, highlighting practical difficulty in achieving the goal. 9
  • Continuous arterial line monitoring is essential because intermittent cuff measurements miss the majority of hypotensive episodes. 8

Safety Thresholds and Practical Limits

  • Avoid hypotension (systolic <90 mmHg or MAP <65 mmHg) because it is clearly linked to worse outcomes and increased mortality. 9
  • Do not extend aggressive MAP augmentation beyond 7 days; the potential benefit appears confined to the first week, with the strongest effect in days 1–3. 8